BUSINESS● LOWSep 8 · Sep 8, 2026, 4:28 PM
Biohaven downgraded at RBC Capital Markets after SK Biopharma deal
Seeking Alpha Tech · global
Biohaven's rating was downgraded by RBC Capital Markets following its deal with SK Biopharma. This indicates a significant financial market reaction to a corporate transaction, affecting the company's investment outlook.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS33m agoTransport authorities demand answers after 4-hour parking meter outageSouth China Morning PostBUSINESS47m agoBayer AG reports mixed Q3 results; updates FY2026 outlookSeeking Alpha Tech